Provisional insolvencyPreliminary measure

CGN Pharma GmbH i.L.

Case number: 70b IN 72/26Court: KölnState: Nordrhein-Westfalen
Buyer interest
20/100
Days since opening
Share capital
Industry

AI-generated dossier

CGN Pharma GmbH i.L. is a company in liquidation based in Cologne, against which an insolvency proceeding (Az. 70b IN 72/26) has been initiated at the Cologne District Court. The commercial register does not have an entry, making it impossible to verify the official business purpose. The company’s own website (cgn-pharma.de) only shows a placeholder page (“Coming Soon”) and contains no information about products, services, or customers. This situation has persisted since at least 2022 (first Wayback entry). Size: Revenue, employee count, and balance sheet data are unknown, as no annual financial statements have been published in the Federal Gazette. The domain has been inactive for several years (45 Wayback captures, the latest from 18.02.2026 shows no content). Trustpilot reviews are absent. The company apparently did not have an English website. Distress signals: The most obvious sig

Register for free to read the complete dossier.

Synthesised from Handelsregister, Bundesanzeiger, §9 notice, web presence and news.

Continue reading — free

Procedure timeline

Milestones of the insolvency proceeding on a single timeline.

TodayPreliminary measure2026-07-16

AI · New

Personal Deal Playbook

An AI-generated action plan for this specific case + your buyer profile — fit, structure, administrator outreach, questions, risks.

With a free account and a buyer profile you get a personalised action plan for EVERY case on this platform.

Preview (locked)

  • Fit•• / 100
  • Estimated asset value•• EUR
  • Budget alignment•••
  • First-outreach draft•• sentences
  • 3 key questions for first call•••
  • 3 case-specific risks•••

Key deadlines

Claim deadline
§174 InsO — deadline for creditors to lodge claims with the administrator.
Report meeting
§29 InsO — first creditors' meeting, administrator presents restructuring vs. liquidation plan.
Verification meeting
§29 InsO — verification of the lodged claims.

Buyer interest score

20/ 100

Proprietary composite: 0-100 based on web resolution, dossier depth, news, procedure type and bid timing.

Web resolution
0/20
Dossier depth
20/20
News activity
0/20
Debtor-led procedure
0/20
Bid-phase timing
0/20

Does this company match your search?

Score the fit against your buyer profile — sector, region, size, deal structure.

45-95 % match probability — full analysis with a free buyer profile.

Score the fit against your buyer profile — sector, region, size, deal structure.

Create buyer profile — free

Network & related entities

Shareholders, directors and related companies derived from commercial register data.

Network analysis for boutique customers

Ownership structures, shareholder lists and related entities are part of the Boutique plan.

Official gazette entry

Full text of the §9 InsO opening decree from insolvenzbekanntmachungen.de.

Amtsgericht Köln, Aktenzeichen: 70b IN 72/26 In dem Insolvenzeröffnungsverfahren über das Vermögen der im Handelsregister des Amtsgerichts Köln unter HRB 81689 eingetragenen CGN Pharma GmbH i.L., Subbelrather Str. 15 A, 50823 Köln, gesetzlich vertreten durch den Liquidator Herrn Sabahaddin Akman, Endenicher Str. 103b, 53115 Bonn Geschäftszweig: der Großhandel sowie der Im- und Export mit pharmazeutischen und chemischen Produkten; sind die am 29.06.2026 angeordneten Sicherungsmaßnahmen durch Beschluss vom 16.07.2026 aufgehoben worden. Köln, 16.07.2026

Similar proceedings

What now? Buyer's guide

How does an insolvency asset deal work? What deadlines matter? When is the best moment to talk to the administrator?

Related knowledge

External sourcesExtra verification sources — deep-linked to the right view when possible.